Hotgen

Hotgen is a biotechnology company based in Beijing that specializes in the research, development, and manufacturing of innovative in-vitro diagnostic products, point-of-care testing solutions, and public safety inspection products. The company focuses on advancing liquid biopsy technology for early cancer screening and has established a multi-omics diagnostic platform that incorporates various biomolecular markers, including proteins, sugar chain exosomes, and DNA methylation. Furthermore, Hotgen's technological framework supports the deployment of diverse biopharmaceuticals such as antibody drugs, live bacteria drugs, and exosome-based therapies. Through its comprehensive development strategy, Hotgen aims to integrate the entire industry chain, facilitating advancements from diagnosis to treatment in the healthcare sector.